Synthesis and Biological Evaluation of RBG Derivatives as Nrf2 Activators for the Treatment of Parkinson’s Disease
represents a promising candidate for further investigation in the development of novel Nrf2-based therapies for PD.
Authors
- Qiu-Heng Zhang
- Jiange Zhang (ORCID: https://orcid.org/0000-0002-1434-6040)
- Shoujiao Peng (ORCID: https://orcid.org/0000-0003-3086-8372)
- Wenqing Shi
- G. L. Lin
- Shaopeng Yu
- Yao Chen
- Wenbo Ye
- Jun-Huan Fu
- Jia-Hua Zhuang
- Gu-Zhou Chen
Institutions
- Shanghai University of Traditional Chinese Medicine (CN)
- Shanghai Institute of Organic Chemistry (CN)
Publication Details
- Journal
- International Journal of Molecular Sciences
- Published
- 2026-04-07
- DOI
- https://doi.org/10.3390/ijms27073326
- Primary Topic
- Genomics, phytochemicals, and oxidative stress
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Shanghai University of Traditional Chinese Medicine